Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users

BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghirardi, Arianna, Scotti, Lorenza, Zambon, Antonella, Della Vedova, Gianluca, Cavalieri D'oro, Luca, Lapi, Francesco, Cipriani, Francesco, Caputi, Achille P., Vaccheri, Alberto, Gregori, Dario, Gesuita, Rosaria, Vestri, Annarita, Staniscia, Tommaso, Mazzaglia, Giampiero, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857168/
https://www.ncbi.nlm.nih.gov/pubmed/24348985
http://dx.doi.org/10.1371/journal.pone.0073159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857168/
https://www.ncbi.nlm.nih.gov/pubmed/24348985
http://dx.doi.org/10.1371/journal.pone.0073159

Ejemplares similares